164. 眼皮膚白皮症 Oculocutaneous albinism Clinical trials / Disease details

臨床試験数 : 15 / 薬物数 : 57 - (DrugBank : 34) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 139

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01838655 (ClinicalTrials.gov)	April 16, 2013	20/4/2013	Nitisinone for Type 1B Oculocutaneous Albinism	A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B	Albinism;Vision Loss	Drug: Nitisinone	National Eye Institute (NEI)	National Human Genome Research Institute (NHGRI)	Completed	18 Years	N/A	All	5	Phase 1/Phase 2	United States